Archive | Of Interest

Regression may predict good prognosis in stage 1 and 2 cutaneous melanomas

Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Study reveals significant role of ADAMTS1 protein in uveal melanoma

Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

The Yin and Yang of BRAF, MEK and CDK4-6 targeted therapy

A new paper from the McArthur & Sheppard Laboratory, by Emily Lelliott et. al.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications

Improvements in treatments for NSCLC, blood cancers, and melanoma continue to accelerate annual drop in overall cancer mortality rates

Overall cancer mortality rates in the United States continued to drop precipitously, falling by 2.4% from 2017-2018, according to the American Cancer Society’s latest Cancer Statistics report.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest